OOIR: Observatory of International Research

Papers

(The H4-Index of Chest is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019	473
The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic	466
Cross-Sectional Studies	458
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China	429
Antithrombotic Therapy for VTE Disease	373
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019	341
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	296
Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1	245
Hospital-Acquired Infections in Critically Ill Patients With COVID-19	222
Executive Summary	221
Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation	212
Persistent Exertional Intolerance After COVID-19	189
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19	159
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma	158
Fluid Response Evaluation in Sepsis Hypotension and Shock	143
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing	142
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019	140
Sample Size Estimation in Clinical Research	139
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension	138
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019	135
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza	135
Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma	133
The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic	130
Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome	129
Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis	128

Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes	126
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis	125
High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure	123
Robotic Bronchoscopy for Peripheral Pulmonary Lesions	122
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU	116
Eosinophilic and Noneosinophilic Asthma	114
Screening for Lung Cancer	113
Physical and Social Environment Relationship With Sleep Health and Disorders	112
Disparities in Sleep Health and Potential Intervention Models	112
Medical Education During the COVID-19 Pandemic	109
The Evolving Landscape of e-Cigarettes	106
The Coronavirus Disease 2019 Pandemic’s Effect on Critical Care Resources and Health-Care Providers	106
Combined Treatment With Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock	105
Diagnosis and Evaluation of Hypersensitivity Pneumonitis	101
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults	101
The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure	95
Pulmonary Thrombosis and Thromboembolism in COVID-19	93
Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis	92
Perioperative Management of Antithrombotic Therapy	92
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis	90
Chest CT Imaging Signature of Coronavirus Disease 2019 Infection	86
Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness	84
Preliminary Findings on Control of Dispersion of Aerosols and Droplets During High-Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask	83
Use of Tracheostomy During the COVID-19 Pandemic	80
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism	79
Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions	78
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic	78
Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits	77
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype	77
Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score	75
Using Causal Diagrams to Improve the Design and Interpretation of Medical Research	74
Right Ventricular Dysfunction in Early Sepsis and Septic Shock	73
Lower vs Higher Fluid Volumes During Initial Management of Sepsis	73
Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease	73
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units	72
Postmortem Lung Findings in a Patient With Asthma and Coronavirus Disease 2019	71
VTE in ICU Patients With COVID-19	71
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality	70
Treatment of Mycobacterium abscessus Pulmonary Disease	69
Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019	67
Fatigue Symptoms During the First Year Following ARDS	67
Standardized Definitions of Bleeding After Transbronchial Lung Biopsy	67